Advertisement
Screener

Connect Biopharma Holdings Limited (CNTB) Investment Income

2.8 / 5 stars · 68/120 Roast Me

Connect Biopharma Holdings Limited Investment Income

Connect Biopharma Holdings Limited (CNTB) reported Investment Income of $5.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-16.

Discontinued › Income Statement › Other Income

ifrs-full:InvestmentIncome · last filed 2024-04-16

CNY

Period endInvestment Income 6 monthInvestment Income 6 month as first filedInvestment Income 12 month
2022-12-31140.00K CNY
20-F · filed 2023-04-11
2022-06-30140.00K CNY
6-K · filed 2023-09-12
526.00K CNY
6-K · filed 2022-09-13
2021-12-31436.00K CNY
20-F · filed 2023-04-11
2021-06-30138.00K CNY
6-K · filed 2022-09-13
2020-12-31672.00K CNY
20-F · filed 2023-04-11
2019-12-31798.00K CNY
20-F · filed 2022-03-31

USD

Period endInvestment Income 12 month
2023-12-31$5.00K
20-F · filed 2024-04-16
2022-12-31$22.00K
20-F · filed 2024-04-16
2021-12-31$68.00K
20-F · filed 2024-04-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Yarrow Bioscience, Inc. (YARW)United States$0.070B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
XBiotech Inc. (XBIT)United States$0.066B-1.56
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
HYPERION DEFI, INC. (HYPD)United States$0.065B
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57